A5051670924- Cardiac Imaging and Diagnostics
- Advanced MRI Techniques and Applications
- Radiation Dose and Imaging
- Cardiovascular Function and Risk Factors
- Cardiomyopathy and Myosin Studies
- Acute Myocardial Infarction Research
- COVID-19 and healthcare impacts
- Amyloidosis: Diagnosis, Treatment, Outcomes
- COVID-19 Clinical Research Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Medical Imaging Techniques and Applications
- Healthcare cost, quality, practices
- Venous Thromboembolism Diagnosis and Management
- Cardiac Arrhythmias and Treatments
- Healthcare Systems and Reforms
- Coronary Interventions and Diagnostics
- Sarcoidosis and Beryllium Toxicity Research
- Public Health in Brazil
- Parathyroid Disorders and Treatments
- Central Venous Catheters and Hemodialysis
- Cardiovascular and Diving-Related Complications
- Diagnosis and Treatment of Venous Diseases
- Healthcare during COVID-19 Pandemic
- Global Health Care Issues
- Medical Imaging and Pathology Studies
Hospital do Coração
2020-2023
Weatherford College
2023
Sociedade Brasileira de Cardiologia
2022
Universidade Estadual Paulista (Unesp)
2021
Universidade Federal de Santa Catarina
2020
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2014
Instituto Dante Pazzanese de Cardiologia
2013
Rafael Advanced Defense Systems (Israel)
2013
Universidade de São Paulo
2013
Hospital Universitário da Universidade de São Paulo
2007
List of Abbreviations and AcronymsHED -11 C -meta-hydroxyephedrine labeled with Carbon-11 PIB-11 -PET -pittsburgh B compound carbon-11 by PET imaging MIBG-123 I -metaiodobenzylguanidine iodine 123 13 NH 3 -ammonia Nitrogen-13 H 2 O-15 O -water Oxygen-15 FDG-18 F -fluorodeoxyglucose Fluorine-18 -PET/TC fluorine-18 hybrid (positron emission tomography coupled computerized tomography) Sodium fluoride-18 -fluorine-18 Fluoride for Amyloid Imaging 201 Hg -mercury-201 Tl -thallium-201 82 Rb...
1. Aspectos Gerais […] Posicionamento Brasileiro sobre o Uso da Multimodalidade de Imagens na Cardio-Oncologia – 2021
Comparative trial of the use antiplatelet and oral anticoagulant
Abstract Background Previous studies have shown that COVID-19 In-Hospital Fatality Rate (IHFR) varies between regions and has been diminishing over time. It is believed the continuous improvement in treatment of patients, age group hospitalized, availability hospital resources might be affecting temporal regional variation IHFR. In this study, we explored how IHFR varied time among groups federative states Brazil. addition, also assessed relationship structure peaks Methods A retrospective...
OBJETIVO: Estabelecer parâmetros de sincronia intra- e interventricular em indivíduos normais compará-los aos pacientes com miocardiopatia dilatada sem distúrbios condução ao eletrocardiograma (ECG). MÉTODOS: Três grupos foram incluídos no estudo: 18 (G1) cardiopatia ECG normal (52+/-12 anos, 29% masculinos); 50 portadores disfunção ventricular esquerda grave, sendo 20 (G2) QRS < 120 ms (51+/-10 75% masculinos) 30 (G3) > (57+/-12 60% masculinos). Todos submetidos à ventriculografia...
Amyloidosis is a systemic infiltrative disease characterized by the extracellular deposition of amyloid fibrils.Heart involvement common and associated with poor prognosis.The most predominant types cardiac amyloidosis (CA) are immunoglobulin light chain (AL) transthyretin (ATTR).Diagnosis CA differentiation between important for prognosis, therapy, genetic counseling.ATTR-CA an under-diagnosed cause heart failure.However, great accomplishments in non-invasive imaging methods, as well...
A amiloidose é uma doença infiltrativa sistêmica caracterizada pela deposição extracelular de fibrilas amiloides. O envolvimento cardíaco comum e está associado a prognóstico desfavorável. Os tipos mais predominantes cardíaca (AC) são por cadeias leves imunoglobulinas (AL) transtirretina (ATTR). diagnóstico AC diferenciação entre os importantes para o prognóstico, terapia aconselhamento genético. AC-ATTR causa subdiagnosticada insuficiência cardíaca. No entanto, grandes conquistas nos...
The infarct size reduction in acute myocardial infarction (AMI) has been studied for more than 50 years.Animal experiments were conducted the 1970s, followed by first clinical studies to reduce (IS), with fibrinolytic agents or mechanical coronary angioplasty (PTCA).The experience of reperfusion indicated that left ventricle function was not normalized 30% patients, and despite unblocking epicardial vessel, demonstrated hemodynamically, there no equivalent perfusion.New concepts emerged such...